$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000162828019013661 Filed on November 07, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.100M	$2.300M	$3.500M
YoY Change	-19.23%	-34.29%	-7.89%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.100M	$2.300M	$3.500M
YoY Change	-19.23%	-34.29%	-7.89%
Operating Profit	-$2.060M	-$2.262M	-$3.516M
YoY Change	-21.31%	-35.67%	-6.44%
Interest Expense	-$900.0K	-$9.000M	$36.70M
YoY Change	-93.48%	-124.52%	-346.31%
% of Operating Profit
Other Income/Expense, Net	$2.245M	$8.777M	-$1.078M
YoY Change	-1263.21%	-914.19%	184.43%
Pretax Income	-$698.0K	-$2.497M	$32.06M
YoY Change	-95.8%	-107.79%	-271.9%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income			0.0%
Net Earnings	-$698.0K	-$2.497M	$32.06M
YoY Change	-95.8%	-107.79%	-271.9%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.03	-$0.12	$1.56
Diluted Earnings Per Share	-$0.03	-$0.12	$1.56
COMMON SHARES
Basic Shares Outstanding	20.65M shares	20.66M	20.56M shares
Diluted Shares Outstanding		20.66M	20.56M shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.00M	$45.00M	$69.60M
YoY Change	-45.3%	-35.34%	75.24%
Cash & Equivalents	$25.03M	$45.04M	$44.50M
Short-Term Investments	$0.00	$0.00	$25.10M
Other Short-Term Assets	$1.300M	$3.300M	$2.100M
YoY Change	18.18%	57.14%	-43.24%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$26.35M	$48.33M	$73.04M
YoY Change	-43.62%	-33.83%	55.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.101M	$2.174M	$1.293M
YoY Change	160.02%	68.14%	-20.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$34.54M	$35.26M	$71.69M
YoY Change	-46.44%	-50.81%	-37.29%
Other Assets	$1.997M	$702.0K	$316.0K
YoY Change	-23.46%	122.15%	0.0%
Total Long-Term Assets	$81.23M	$82.52M	$105.3M
YoY Change	-17.95%	-21.64%	-28.47%
TOTAL ASSETS
Total Short-Term Assets	$26.35M	$48.33M	$73.04M
Total Long-Term Assets	$81.23M	$82.52M	$105.3M
Total Assets	$107.6M	$130.8M	$178.4M
YoY Change	-26.18%	-26.63%	-8.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$39.00K	$117.0K	$17.00K
YoY Change	-76.36%	588.24%	-90.06%
Accrued Expenses	$627.0K	$1.138M	$2.213M
YoY Change	-71.26%	-48.58%	-11.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$22.10M
YoY Change		-100.0%	-44.89%
Total Short-Term Liabilities	$2.429M	$3.708M	$28.34M
YoY Change	-92.63%	-86.92%	-37.93%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$63.40M
YoY Change	-100.0%	-100.0%	41.2%
Other Long-Term Liabilities	$1.027M	$1.728M	$3.106M
YoY Change	-63.37%	-44.37%	-11.36%
Total Long-Term Liabilities	$1.027M	$1.728M	$3.106M
YoY Change	-63.37%	-44.37%	-11.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.429M	$3.708M	$28.34M
Total Long-Term Liabilities	$1.027M	$1.728M	$3.106M
Total Liabilities	$5.836M	$7.912M	$94.84M
YoY Change	-92.59%	-91.66%	0.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$697.2M	-$675.8M	-$714.5M
YoY Change	-4.63%	-5.41%	2.55%
Common Stock	$813.0M	$812.8M	$813.3M
YoY Change	-0.01%	-0.06%	-0.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$14.02M	$14.00M	$15.28M
YoY Change	-6.51%	-8.41%	-24.05%
Treasury Stock Shares	$930.0K	928.0K shares	926.0K shares
Shareholders Equity	$101.7M	$122.9M	$83.50M
YoY Change
Total Liabilities & Shareholders Equity	$107.6M	$130.8M	$178.4M
YoY Change	-26.18%	-26.63%	-8.2%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$698.0K	-$2.497M	$32.06M
YoY Change	-95.8%	-107.79%	-271.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.500M	-$6.300M	-$5.000M
YoY Change	-79.73%	26.0%	21.95%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$1.600M	$23.00M	$23.60M
YoY Change	-112.8%	-2.54%	-437.14%
Cash From Investing Activities	$1.600M	$23.00M	$23.60M
YoY Change	-112.8%	-2.54%	-437.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-20.70M	-44.60M	0.000
YoY Change	25.45%		-100.0%
NET CHANGE
Cash From Operating Activities	-1.500M	-6.300M	-5.000M
Cash From Investing Activities	1.600M	23.00M	23.60M
Cash From Financing Activities	-20.70M	-44.60M	0.000
Net Change In Cash	-20.60M	-27.90M	18.60M
YoY Change	-43.41%	-250.0%	-234.78%
FREE CASH FLOW
Cash From Operating Activities	-$1.500M	-$6.300M	-$5.000M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000086115
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20652661	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SAFEGUARD SCIENTIFICS INC
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2019Q3	sfe	Debt Instrument Accrued Interest Repaid DebtInstrumentAccruedInterestRepaid	900000	USD
CY2019Q3	sfe	Debt Instrument Gain Lossfrom Covenant Liability DebtInstrumentGainLossfromCovenantLiability	-4100000	USD
CY2019Q3	sfe	Debt Instrument Interest Repaid DebtInstrumentInterestRepaid	4100000	USD
CY2001Q4	sfe	Future Annual Payment To Chairman And Chief Executive Officer FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer	650000	USD
CY2019Q3	sfe	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	613000	USD
CY2019Q2	sfe	Lessor Operating Lease Numberof Renewal Terms LessorOperatingLeaseNumberofRenewalTerms	3	extension
CY2019Q3	sfe	Lessor Operating Lease Paymentstobe Received Six Years LessorOperatingLeasePaymentstobeReceivedSixYears	573000	USD
CY2018Q4	sfe	Lineof Credit Facility Repayment Feature Current LineofCreditFacilityRepaymentFeatureCurrent	5060000	USD
CY2019Q3	sfe	Lineof Credit Facility Repayment Feature Current LineofCreditFacilityRepaymentFeatureCurrent	0	USD
CY2018Q3	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	-14000	USD
	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	67000	USD
CY2019Q3	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	6000	USD
CY2018Q3	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	33000	USD
	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	33000	USD
CY2019Q3	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	-31000	USD
CY2019Q3	sfe	Partner Companies Not Consolidated In Financial Statements PartnerCompaniesNotConsolidatedInFinancialStatements	15	nonconsolidated_partner_company
CY2018Q1	sfe	Saleof Stock Individual Ownership Percent Maximum SaleofStockIndividualOwnershipPercentMaximum	0.0499
CY2018Q1	sfe	Stock Issued During Period Value Restricted Stock Award Withheldfor Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldforTaxes	150000	USD
CY2018Q2	sfe	Stock Issued During Period Value Restricted Stock Award Withheldfor Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldforTaxes	50000	USD
CY2018Q3	sfe	Stock Issued During Period Value Restricted Stock Award Withheldfor Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldforTaxes	34000	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	USD
CY2019Q2	sfe	Stock Issued During Period Value Restricted Stock Award Withheldfor Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldforTaxes	31000	USD
CY2019Q3	sfe	Stock Issued During Period Value Restricted Stock Award Withheldfor Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldforTaxes	30000	USD
CY2019Q1	sfe	Stock Issued During Period Value Restricted Stock Award Withheldfor Taxes Cancelled StockIssuedDuringPeriodValueRestrictedStockAwardWithheldforTaxesCancelled	149000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	165000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	117000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2182000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1138000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	810928000	USD
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	810649000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	277000	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	333000	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	243000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	417000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	269000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	248000	USD
CY2018Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	15325000	USD
CY2019Q3	us-gaap	Advances To Affiliate AdvancesToAffiliate	16888000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	243000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	853000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	248000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	934000	USD
CY2018Q4	us-gaap	Assets Assets	145737000	USD
CY2019Q3	us-gaap	Assets Assets	130849000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	48827000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	48328000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7703000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45000000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45039000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27087000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44522000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8203000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45564000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	17435000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	37361000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	32079000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1094000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2497000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	55234000	USD
CY2018Q4	us-gaap	Cost Method Investments CostMethodInvestments	15771000	USD
CY2019Q3	us-gaap	Cost Method Investments CostMethodInvestments	27494000	USD
CY2019Q3	us-gaap	Debt Instrument Repurchased Face Amount DebtInstrumentRepurchasedFaceAmount	44500000	USD
CY2019Q3	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	300000	USD
CY2018Q3	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20561000	USD
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20535000	USD
CY2019Q3	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20657000	USD
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20623000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.68
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.68
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3433000	USD
CY2019Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2057000	USD
CY2019Q3	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	23624000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	157952000	USD
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	14448000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	61401000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-35063000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-121440000	USD
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-30470000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-99282000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	42396000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	241023000	USD
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	28940000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	112540000	USD
CY2018Q4	us-gaap	Equity Method Investments EquityMethodInvestments	64489000	USD
CY2019Q3	us-gaap	Equity Method Investments EquityMethodInvestments	35263000	USD
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	4500000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3516000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14253000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2262000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7922000	USD
CY2018Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	37955000	USD
CY2019Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	0	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	32060000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	994000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2497000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	55259000	USD
CY2018Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	39246000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	27452000	USD
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3440000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	65324000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0	shares
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0	shares
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0	shares
CY2018Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3310000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	9422000	USD
CY2019Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	5806000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	14023000	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	718000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2182000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	234000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1870000	USD
CY2018Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	95585000	USD
CY2019Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	79645000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.12
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4126000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	826000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	607000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	601000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	595000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	707000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	177000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1253000	USD
CY2019Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	3600000	USD
CY2019Q3	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	3617000	USD
CY2019Q3	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	556000	USD
CY2019Q3	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	540000	USD
CY2019Q3	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	125000	USD
CY2019Q3	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	789000	USD
CY2019Q3	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	525000	USD
CY2019Q3	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	509000	USD
CY2019Q2	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P6M
CY2019Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P18M
CY2018Q4	us-gaap	Liabilities Liabilities	78758000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	7912000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	145737000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	130849000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32940000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3708000	USD
CY2018Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	22100000	USD
CY2019Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2018Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	43014000	USD
CY2019Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8486000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-68778000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	44570000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	124682000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18649000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18543000	USD
CY2018Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3516000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14253000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2262000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7922000	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2873000	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	396000	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2476000	USD
CY2018Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	100000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	400000	USD
CY2019Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	100000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	400000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	517000	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	702000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	82000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4965000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8777000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10010000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-31000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2804000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1728000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1078000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	12098000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	4954000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2252000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	234000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	210000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3250000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	9500000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	24858000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	57243000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2019Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2019Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2669000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2764000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	10652000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	0	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	69912000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	101190000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	35000000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	4211000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	95189000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-6170000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	-24896000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	32060000	USD
	us-gaap	Profit Loss ProfitLoss	994000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	21663000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	36093000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-2497000	USD
	us-gaap	Profit Loss ProfitLoss	55259000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	808000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2174000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	41000000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2019Q3	us-gaap	Repayments Of Debt RepaymentsOfDebt	49500000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	68568000	USD
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	USD
CY2019Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	525000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-731105000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-675846000	USD
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	30000	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	30000	shares
CY2018Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	81796000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	75835000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	51221000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	83509000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	66979000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	88879000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	125216000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	122937000	USD
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	914000	shares
CY2019Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	928000	shares
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	15001000	USD
CY2019Q3	us-gaap	Treasury Stock Value TreasuryStockValue	13998000	USD
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20561000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20535000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20657000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20623000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20561000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20535000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20657000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20623000	shares

Files In Submission

Name	View Source	Status
0001628280-19-013661-index-headers.html	Edgar Link	pending
0001628280-19-013661-index.html	Edgar Link	pending
0001628280-19-013661.txt	Edgar Link	pending
0001628280-19-013661-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20190930.xml	Edgar Link	completed
sfe-20190930.xsd	Edgar Link	pending
sfe-20190930_cal.xml	Edgar Link	unprocessable
sfe-20190930_def.xml	Edgar Link	unprocessable
sfe-20190930_lab.xml	Edgar Link	unprocessable
sfe-20190930_pre.xml	Edgar Link	unprocessable
sfe-2019xq3.htm	Edgar Link	pending
sfe-2019xq3xex311.htm	Edgar Link	pending
sfe-2019xq3xex312.htm	Edgar Link	pending
sfe-2019xq3xex321.htm	Edgar Link	pending
sfe-2019xq3xex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2019 Q4 Form 10-Q Financial Statement

#000162828019013661 Filed on November 07, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2019 Q4 Form 10-Q Financial Statement

#000162828019013661 Filed on November 07, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes